Cart
sales@molnova.com
BI 187004
CAS No. 1303515-32-3
BI 187004( BI187004 | VTP-34072 )
Catalog No. M11216 CAS No. 1303515-32-3
BI 187004 (VTP-34072) is a novel potent, selective 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor intended to treat type 2 diabetes mellitus (T2D).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 202 | In Stock |
|
| 5MG | 188 | In Stock |
|
| 10MG | 353 | In Stock |
|
| 25MG | 652 | In Stock |
|
| 50MG | 909 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI 187004
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI 187004 (VTP-34072) is a novel potent, selective 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor intended to treat type 2 diabetes mellitus (T2D).
-
DescriptionBI 187004 (VTP-34072) is a novel potent, selective 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor intended to treat type 2 diabetes mellitus (T2D).Diabetes Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsBI187004 | VTP-34072
-
PathwayMetabolic Enzyme/Protease
-
Target11β-HSD
-
Recptor11β-HSD
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1303515-32-3
-
Formula Weight342.402
-
Molecular FormulaC21H18N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(4aR,9aS)-1-(1H-benzo[d]imidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydro1H-indeno[2,1-b]pyridine-6-carbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Maw HH, et al. Drug Metab Dispos. 2018 Mar 7. pii: dmd.117.079764.
molnova catalog
related products
-
SKI-2852
A highly potent, selective, and orally bioavailable 11β-HSD1 inhibitor with IC50 of 2.9 and 1.6 nM for hHSD1 and mHSD1, respectively.
-
BI 135585
BI 135585 (BI-135585, BI135585) is a potent, selective, orally active 11β-HSD1 inhibitor with IC50 of 4.3 nM and 53 nM in human adipocytes and primary human adipose tissue, respectively.
-
INCB13739
INCB13739 (INCB-13739) is a potent, selective, oral 11βHSD1 inhibitor (IC50=1.1 nM) with high seelctivity over other dehydrogenases, glucocorticoid and mineralocorticoid receptors.
